DE602004031225D1 - 3-oxa-8-azaprostaglandinanaloga als mittel zum senken des augeninnendrucks - Google Patents
3-oxa-8-azaprostaglandinanaloga als mittel zum senken des augeninnendrucksInfo
- Publication number
- DE602004031225D1 DE602004031225D1 DE602004031225T DE602004031225T DE602004031225D1 DE 602004031225 D1 DE602004031225 D1 DE 602004031225D1 DE 602004031225 T DE602004031225 T DE 602004031225T DE 602004031225 T DE602004031225 T DE 602004031225T DE 602004031225 D1 DE602004031225 D1 DE 602004031225D1
- Authority
- DE
- Germany
- Prior art keywords
- azaprostaglandinanaloga
- reminder
- oxa
- lowering eye
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000010412 Glaucoma Diseases 0.000 abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/453,207 US6734206B1 (en) | 2003-06-02 | 2003-06-02 | 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
PCT/US2004/016516 WO2004108670A1 (en) | 2003-06-02 | 2004-05-25 | 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004031225D1 true DE602004031225D1 (de) | 2011-03-10 |
Family
ID=32230466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004031225T Expired - Lifetime DE602004031225D1 (de) | 2003-06-02 | 2004-05-25 | 3-oxa-8-azaprostaglandinanaloga als mittel zum senken des augeninnendrucks |
Country Status (10)
Country | Link |
---|---|
US (1) | US6734206B1 (de) |
EP (1) | EP1638936B1 (de) |
JP (1) | JP2006526638A (de) |
AT (1) | ATE496886T1 (de) |
AU (1) | AU2004245492B2 (de) |
BR (1) | BRPI0410926A (de) |
CA (1) | CA2528010C (de) |
DE (1) | DE602004031225D1 (de) |
ES (1) | ES2358513T3 (de) |
WO (1) | WO2004108670A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6734201B1 (en) * | 2003-06-02 | 2004-05-11 | Allergan, Inc. | 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
DK1960353T3 (da) | 2005-11-03 | 2014-05-26 | Allergan Inc | Prostaglandiner og analoger som midler til sænkning af intraokulært tryk |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
US8783923B2 (en) * | 2010-03-18 | 2014-07-22 | Chung Yuan Christian University | Auto lamp structure |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034413A (en) | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
US5028624A (en) | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
US4994274A (en) | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
CA2021316C (en) | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
US6545045B1 (en) * | 1998-12-24 | 2003-04-08 | Alcon Manufacturing, Ltd. | Prostaglandin E agonists for treatment of glaucoma |
AP2002002555A0 (en) | 1999-12-22 | 2002-06-30 | Pfizer Prod Inc | EP4 Receptor selective agonists in the treatment of osteoporosis. |
IL141120A0 (en) | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
US20010056060A1 (en) | 2000-02-07 | 2001-12-27 | Cameron Kimberly O. | Treatment of osteoporsis with EP2/EP4 receptor selective agonists |
JP4063468B2 (ja) | 2000-02-22 | 2008-03-19 | 株式会社カネボウ化粧品 | 寒天被覆処理顔料およびメイクアップ化粧料 |
WO2002024647A1 (fr) | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
CN1476429A (zh) * | 2000-11-27 | 2004-02-18 | �Ʒ� | 治疗骨质疏松的ep4受体选择性激动剂 |
WO2002102389A1 (en) | 2001-06-14 | 2002-12-27 | Allergan, Inc. | 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
EP1409455B1 (de) * | 2001-07-16 | 2006-01-04 | F. Hoffmann-La Roche Ag | Prostaglandinanaloga als ep4-rezeptoragonisten |
BR0211167A (pt) | 2001-07-16 | 2004-08-10 | Hoffmann La Roche | Derivados de 2-pirrolidona como agonistas de prostanóides |
WO2003009872A1 (en) | 2001-07-23 | 2003-02-06 | Ono Pharmaceutical Co., Ltd. | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
MXPA04009036A (es) * | 2002-03-18 | 2005-01-25 | Pfizer Prod Inc | Uso de agonistas del receptor ep4 selectivos para el tratamiento de la insuficiencia hepatica, perdida de permeabilidad del ductus arterioso, glaucoma o hipertension ocular. |
DE60307607T2 (de) * | 2002-03-18 | 2007-08-09 | Pfizer Products Inc., Groton | Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten |
-
2003
- 2003-06-02 US US10/453,207 patent/US6734206B1/en not_active Expired - Fee Related
-
2004
- 2004-05-25 AT AT04753359T patent/ATE496886T1/de not_active IP Right Cessation
- 2004-05-25 JP JP2006514964A patent/JP2006526638A/ja active Pending
- 2004-05-25 ES ES04753359T patent/ES2358513T3/es not_active Expired - Lifetime
- 2004-05-25 DE DE602004031225T patent/DE602004031225D1/de not_active Expired - Lifetime
- 2004-05-25 WO PCT/US2004/016516 patent/WO2004108670A1/en active Application Filing
- 2004-05-25 BR BRPI0410926-0A patent/BRPI0410926A/pt not_active IP Right Cessation
- 2004-05-25 CA CA2528010A patent/CA2528010C/en not_active Expired - Fee Related
- 2004-05-25 EP EP04753359A patent/EP1638936B1/de not_active Expired - Lifetime
- 2004-05-25 AU AU2004245492A patent/AU2004245492B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP1638936B1 (de) | 2011-01-26 |
CA2528010C (en) | 2012-01-24 |
BRPI0410926A (pt) | 2006-06-27 |
CA2528010A1 (en) | 2004-12-16 |
US6734206B1 (en) | 2004-05-11 |
ATE496886T1 (de) | 2011-02-15 |
JP2006526638A (ja) | 2006-11-24 |
EP1638936A1 (de) | 2006-03-29 |
AU2004245492A1 (en) | 2004-12-16 |
WO2004108670A1 (en) | 2004-12-16 |
AU2004245492B2 (en) | 2010-08-19 |
ES2358513T3 (es) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50312946D1 (de) | Difluormethyl thiazolyl carboxanilide | |
ATE502633T1 (de) | Cyclosporins zur behandlung und vorbeugung von augenerkrankungen | |
NO20071719L (no) | Pyridylinhibitorer for "hedgehog"-signalisering | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
TW200700070A (en) | Enhanced bimatoprost ophthalmic solution | |
NO20070606L (no) | Inhibitorer av IAP | |
BR0310047A (pt) | Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular | |
DE50306845D1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
TW200630374A (en) | Thiazolyldihydroindazoles | |
DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
NO20064282L (no) | Morfolinforbindelser | |
DE60219614D1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
TW200500339A (en) | Pyrrolidine derivatives, and process for the preparation | |
CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
EP1627635A3 (de) | Benzothiazolium Verbindungen zur Verwendung in Methoden zur Hemmung der NO Produktion und von TNF alpha und zur Behandlung von Coronavirus Infektionen | |
DE602005017815D1 (de) | Behandlung von entzündlicher darmerkrankung | |
DE60234919D1 (de) | 3, 7 oder 3 und 7 thia- oder oxaprostansäure derivate als mittel zur senkung des augeninnendrucks | |
IL183636A0 (en) | Quinoline derivative, use and production thereof, and drug containing the same | |
WO2006050861A3 (en) | Statine derivatives for the treatment of alzheimer's disease | |
PL1874739T3 (pl) | Farmaceutycznie czynne diazepany | |
EA200701813A1 (ru) | Новые амидозамещенные 6-фенилфенантридины | |
DE602004031225D1 (de) | 3-oxa-8-azaprostaglandinanaloga als mittel zum senken des augeninnendrucks |